These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23408123)
1. A clinico-pathological study on cancer in sclerosing adenosis. Ogura K; Horii R; Oosako T; Iwase T; Akiyama F Breast Cancer; 2014 Nov; 21(6):732-7. PubMed ID: 23408123 [TBL] [Abstract][Full Text] [Related]
2. Intraductal carcinoma of the breast arising in sclerosing adenosis. Ichihara S; Aoyama H Pathol Int; 1994 Sep; 44(9):722-6. PubMed ID: 7804435 [TBL] [Abstract][Full Text] [Related]
3. Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ. Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Nishida C; Morita T; Sato Y; Hayashi T; Kato A; Aoyama H; Yoshikawa K Histopathology; 2011 May; 58(6):835-46. PubMed ID: 21401704 [TBL] [Abstract][Full Text] [Related]
4. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. Yoshida A; Hayashi N; Akiyama F; Yamauchi H; Uruno T; Kikuchi M; Yagata H; Tsugawa K; Suzuki K; Nakamura S; Tsunoda H Clin Breast Cancer; 2012 Dec; 12(6):398-403. PubMed ID: 23083502 [TBL] [Abstract][Full Text] [Related]
7. When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Gill HK; Ioffe OB; Berg WA Radiology; 2003 Jul; 228(1):50-7. PubMed ID: 12738875 [TBL] [Abstract][Full Text] [Related]
8. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast. Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512 [TBL] [Abstract][Full Text] [Related]
11. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events. Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive carcinoma of the breast presenting in adenosis. Oberman HA; Markey BA Mod Pathol; 1991 Jan; 4(1):31-5. PubMed ID: 1850517 [TBL] [Abstract][Full Text] [Related]
13. A unique case of sclerosing polycystic adenosis of the sinonasal tract. Su A; Bhuta SM; Berke GS; Lai CK Hum Pathol; 2013 Sep; 44(9):1937-40. PubMed ID: 23465282 [TBL] [Abstract][Full Text] [Related]
14. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403 [TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features. Ishikawa Y; Horiguchi J; Toya H; Nakajima H; Hayashi M; Tagaya N; Takeyoshi I; Oyama T Cancer Sci; 2011 Mar; 102(3):656-62. PubMed ID: 21214677 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer. Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119 [TBL] [Abstract][Full Text] [Related]
17. [Nodular sclerosing adenosis (adenosis tumor) of the breast. An immunohistologic study particularly in reference to the relationship with radial cicatrix and to the differential diagnosis with tubular carcinoma]. Lanzafame S Pathologica; 1989; 81(1073):251-66. PubMed ID: 2641538 [TBL] [Abstract][Full Text] [Related]
18. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis]. Zhang B; Liu FF; Ma YJ; Gu F Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959 [TBL] [Abstract][Full Text] [Related]
19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast. Vogl G; Dietze O; Hauser-Kronberger C Histopathology; 2005 Dec; 47(6):617-24. PubMed ID: 16324200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]